Lack of an Effect of High Dose Isoflavones in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy

Journal of Urology

Volumn 182, Issue 5, 2009, Pages 2265-2273

  Sharma, Preetika ^a   Wisniewski, Amy ^b   Braga Basaria, Milena ^c   Xu, Xiaoqiang ^d   Yep, Mary ^d   Denmeade, Samuel ^e   Dobs, Adrian S ^d   DeWeese, Theodore ^d   Carducci, Michael ^e   Basaria, Shehzad ^c  

^a GEORGETOWN UNIVERSITY   (United States)

^b Oklahoma University School of Community Medicine   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

antiandrogens; isoflavones; prostate; prostatic neoplasms; quality of life

Indexed keywords

ANTIANDROGEN; DAIDZEIN; GENISTEIN; GLYCITEIN; GONADORELIN DERIVATIVE; ISOFLAVONE DERIVATIVE; NEOARSPHENAMINE; PLACEBO; SOYBEAN PROTEIN;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; ASIAN; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; HOT FLUSH; HUMAN; MALE; OUTCOME ASSESSMENT; PILOT STUDY; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEXUAL FUNCTION; SEXUAL INTERCOURSE; SLEEP PATTERN; TERTIARY HEALTH CARE; TREATMENT DURATION; TREATMENT OUTCOME; UNITED STATES; PROSTATE TUMOR;

AGED; ANDROGEN ANTAGONISTS; DOUBLE-BLIND METHOD; HUMANS; ISOFLAVONES; MALE; PILOT PROJECTS; PROSTATIC NEOPLASMS;

EID: 70350447619     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.07.030     Document Type: Article

References (30)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43
2. Bolla M., Gonzalez D., Warde P., et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 337 (1997) 295
3. Shahani S., Braga-Basaria M., and Basaria S. Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis. J Clin Endocrinol Metab 93 (2008) 2042
4. Smith M.R. Androgen deprivation therapy for prostate cancer: new concepts and concerns. Curr Opin Endocrinol Diabetes Obes 14 (2007) 247
5. Basaria S., Lieb II J., Tang A.M., et al. Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrinol (Oxf) 56 (2002) 779
6. Basaria S., Muller D.C., Carducci M.A., et al. Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer 106 (2006) 581
7. Cherrier M.M., Rose A.L., and Higano C. The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer. J Urol 170 (2003) 1808
8. Carani C., Qin K., Simoni M., et al. Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 337 (1997) 91
9. Salminen E.K., Portin R.I., Koskinen A.I., et al. Estradiol and cognition during androgen deprivation in men with prostate carcinoma. Cancer 103 (2005) 1381
10. Harle L.K., Maggio M., Shahani S., et al. Endocrine complications of androgen-deprivation therapy in men with prostate cancer. Clin Adv Hematol Oncol 4 (2006) 687
11. Blackard C.E. The Veterans' Administration Cooperative Urological Research Group studies of carcinoma of the prostate: a review. Cancer Chemother Rep 59 (1975) 225
12. Murkies A.L., Wilcox G., and Davis S.R. Clinical review 92: phytoestrogens. J Clin Endocrinol Metab 83 (1998) 297
13. Kuiper G.G., Lemmen J.G., Carlsson B., et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139 (1998) 4252
14. de Kleijn M.J., van der Schouw Y.T., Wilson P.W., et al. Intake of dietary phytoestrogens is low in postmenopausal women in the United States: the Framingham study. J Nutr 131 (2001) 1826
15. Lephart E.D., Adlercreutz H., and Lund T.D. Dietary soy phytoestrogen effects on brain structure and aromatase in Long-Evans rats. Neuroreport 12 (2001) 3451
16. Basaria S., Wisniewski A., Dupree K., et al. Effects of high-dose isoflavones on cognition, quality of life, androgens and lipoproteins in postmenopausal women. J Endocrinol Invest 32 (2009) 150
17. File S.E., Jarrett N., Fluck E., et al. Eating soya improves human memory. Psychopharmacology (Berl) 157 (2001) 430
18. Rosen R.C., Riley A., Wagner G., et al. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49 (1997) 822
19. Watts R.J. Dimensions of sexual health. Am J Nurs 79 (1979) 1568
20. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14 (1991) 540
21. Alder E. The Blatt-Kupperman menopausal index: a critique. Maturitas 29 (1998) 19
22. Basaria S. Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth. J Androl 29 (2008) 534
23. Tang G.W. The climacteric of Chinese factory workers. Maturitas 19 (1994) 177
24. McEwen B.S., and Alves S.E. Estrogen actions in the central nervous system. Endocrinol Rev 20 (1999) 279
25. Kreijkamp-Kaspers S., Kok L., Grobbee D.E., et al. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA 292 (2004) 65
26. Moyad M.A. Complementary/alternative therapies for reducing hot flashes in prostate cancer patients: reevaluating the existing indirect data from studies of breast cancer and postmenopausal women. Urology 59 (2002) 20
27. Srilatha B., and Adaikan P.G. Estrogen and phytoestrogen predispose to erectile dysfunction: do ER-alpha and ER-beta in the cavernosum play a role?. Urology 63 (2004) 382
28. Pan L., Xia X., Feng Y., et al. Exposure to the phytoestrogen daidzein attenuates apomorphine-induced penile erection concomitant with plasma testosterone level reduction in dose- and time-related manner in adult rats. Urology 70 (2007) 613
29. Guise T.A., Oefelein M.G., Eastham J.A., et al. Estrogenic side effects of androgen deprivation therapy. Rev Urol 9 (2007) 163
30. Gerber G.S., Zagaja G.P., Ray P.S., et al. Transdermal estrogen in the treatment of hot flashes in men with prostate cancer. Urology 55 (2000) 97